{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-22-001588","form_type":"8-K","ticker":"TDOC","cik":"0001477449","company_name":"Teladoc Health, Inc.","filed_at":"2022-02-22T23:59:59+00:00","discovered_at":"2026-05-14T18:04:06.650042+00:00","generated_at":"2026-06-27T06:05:33.905024+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Teladoc Q4 revenue $554M (+45% YoY); 2022 guidance $2.55-2.65B","bullets":["Q4 revenue $554.2M (+45% YoY); full year 2021 revenue $2.03B (+86% YoY).","Q4 net loss improved to $0.07 per share from $3.07 loss; full year net loss $2.73 per share.","Adjusted EBITDA Q4 $77.1M (+53% YoY); full year $267.8M (+111% YoY).","2022 revenue guidance $2.55-2.65B, representing 25-30% growth over 2021.","Full year cash from operations $194.0M vs ($53.5M) prior year, a positive swing."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-22-001588","json":"https://secwatch.observer/filing/0001558370-22-001588.json","markdown":"https://secwatch.observer/filing/0001558370-22-001588.md","text":"https://secwatch.observer/filing/0001558370-22-001588.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1477449/000155837022001588/0001558370-22-001588-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1477449/000155837022001588/tdoc-20220222x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T06:05:33.905024+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}